TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/21/23 20:21 | 12/19/23 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Akamine Scott | MA | O | GC | M.d | 0 | 0.00 | 0 | 14 | 7 | D | |||||||||||||||
12/21/23 20:21 | 12/20/23 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Akamine Scott | MA | O | GC | S.d | -293 | 41.42 | 0 | -7 | -49 | 7 | D | ||||||||||||||
12/7/23 19:45 | 12/5/23 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Akamine Scott | MA | O | GC | M.dm | 230 | 13.17 | 0 | 18 | 1 | D | |||||||||||||||
12/7/23 19:45 | 12/5/23 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Akamine Scott | MA | O | GC | S.dm | -676 | 38.64 | 0 | -18 | -97 | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |